Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antibody Titer”

47 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 47 results

Post-approval studies (Phase 4)Study completedNCT02039440
What this trial is testing

6-year Antibody Check After Third Vaccination Against Japanese Encephalitis

Who this might be right for
Post Other Specified Vaccination Encephalitis
Medical University of Vienna 67
Post-approval studies (Phase 4)Study completedNCT04222023
What this trial is testing

Intravenous Immunoglobulins for Prevention of BKV Infection in Kidney Transplant Recipients According to BKV Genotype-specific Neutralizing Antibody Titers at the Day of Transplantation.

Who this might be right for
Kidney Transplantation
University Hospital, Strasbourg, France 359
Post-approval studies (Phase 4)Study completedNCT01700621
What this trial is testing

Coadministration of Measles-rubella and Rotavirus Vaccines

Who this might be right for
Measles Antibody SeroconversionRubella Antibody SeroconversionRotavirus Geometric Mean Titer (GMT)+1 more
PATH 482
Not applicableStudy completedNCT02500511
What this trial is testing

Persistence of Protective Antibody Titers 12-24 Months After NmVac4-A/C/Y/W-135-DT Vaccination: Follow Up Study

Who this might be right for
Meningococcal MeningitisMeningococcal Infections
JN-International Medical Corporation 50
Large-scale testing (Phase 3)Ended earlyNCT04361253
What this trial is testing

Evaluation of SARS-CoV-2 (COVID-19) Antibody-containing Plasma thErapy

Who this might be right for
COVIDInfectious Disease
Brigham and Women's Hospital 45
Not applicableUnknownNCT01298869
What this trial is testing

The Study of Immunogenicity of Quadrivalent Vaccine Against Human Papilloma Virus (HPV) Types 6, 11, 16, and 18 (HPV-6/11/16/18) in Chronic Kidney Disease (CKD) Patients

Who this might be right for
Chronic Kidney Disease, Stage IV (Severe)Chronic Kidney Disease, Stage V
Chulalongkorn University 60
Early research (Phase 1)Study completedNCT02139657
What this trial is testing

An Open-label, Single-Arm Study to Evaluate the Safety and Rabies Virus Antibody Titers of Intramuscularly Administered Rabies Immune Globulin (Human)

Who this might be right for
Rabies
Grifols Therapeutics LLC 12
Not applicableEnrolling By InvitationNCT02511002
What this trial is testing

Long-term Observation of Hemagglutinin and Neuraminidase Inhibition Antibody Titers After Influenza Challenge

Who this might be right for
Post Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 200
Not applicableUnknownNCT01046227
What this trial is testing

Antibody Titer Analysis After H1N1 Vaccination in Pediatric Haemato-oncology Patients

Who this might be right for
Serology AnalysisNovel H1N1 Influenza VaccinationPediatric Haemato-oncology Patients
National Taiwan University Hospital 50
Not applicableStudy completedNCT02006784
What this trial is testing

Pilot Study to Assess Flares Following Inactivated Influenza Vaccine in Children With Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus Erythematosus (SLE)
Vanderbilt University 17
Not applicableUnknownNCT01646411
What this trial is testing

300 Antibody Diagnostic Test Kit

Who this might be right for
Acute Bacterial InfectionsAcute Viral Infections
The Plasma Source 300
Not applicableStudy completedNCT05104359
What this trial is testing

COVID-19 Quantitative Antibody Titers & Booster Vaccinations

Who this might be right for
COVID-19COVID-19 VaccinesImmunogenicity, Vaccine
Epividian 825
Early research (Phase 1)Ended earlyNCT06597656
What this trial is testing

A Gene Transfer Therapy to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) Following Therapeutic Plasma Exchange (Plasmapheresis) in Participants With Duchenne Muscular Dystrophy (DMD) and Pre-existing Antibodies to AAVrh74

Who this might be right for
Duchenne Muscular Dystrophy
Sarepta Therapeutics, Inc. 3
Testing effectiveness (Phase 2)Study completedNCT04566276
What this trial is testing

ChulaCov19 Vaccine in Healthy Adults

Who this might be right for
COVID-19 VaccineSafety Issues
Chulalongkorn University 192
Testing effectiveness (Phase 2)Study completedNCT00069316
What this trial is testing

Omr-IgG-am(Trademark) for Treating Patients With or at High Risk for West Nile Virus Disease

Who this might be right for
West Nile Virus
National Institutes of Health Clinical Center (CC) 2
Large-scale testing (Phase 3)Study completedNCT01022749
What this trial is testing

Efficacy Safety Study of Flu Vaccine in Immunodepression Patients

Who this might be right for
Inflammatory Bowel Disease (IBD)
Assistance Publique - Hôpitaux de Paris 228
Early research (Phase 1)Study completedNCT00143741
What this trial is testing

Use of Atorvastatin (Lipitor) to Decrease Panel Reactive Antibody Titers

Who this might be right for
End-Stage Kidney Disease
University of Chicago 20
Not applicableStudy completedNCT07054372
What this trial is testing

Comparison of the Impact of Different Suspension Mediums on ABO Antibody Titres.

Who this might be right for
Healthy Blood Donor
Institute of Liver and Biliary Sciences, India 200
Not applicableStudy completedNCT01338688
What this trial is testing

The Change of the Tetanus Antibody Titer After Single Injection of Td and Simultaneous Injection of TIG With Td

Who this might be right for
Tetanus
Seoul National University Hospital 250
Early research (Phase 1)Ended earlyNCT06241950
What this trial is testing

A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) Following Imlifidase Infusion in Participants With Duchenne Muscular Dystrophy (DMD) Determined to Have Pre-existing Antibodies to Recombinant Adeno-Associated Virus Serotype (rAAVrh74)

Who this might be right for
Duchenne Muscular Dystrophy
Sarepta Therapeutics, Inc. 5
Load More Results